Medicine & Health

New research led by Washington University researchers identifies a common genetic signature that may increase a person’s risk of developing substance use disorders. The work eventually could lead to universal therapies to treat multiple substance use disorders and potentially help people diagnosed with more than one.

Three early-career scientists who have conducted their research at Washington University School of Medicine in St. Louis have been honored with the Young Physician-Scientist Award by the American Society for Clinical Investigation (ASCI).

Michael Vahey at the McKelvey School of Engineering, will investigate how influenza virus proteins contribute to the spread of infection with a five-year, nearly $2 million grant from the National Institutes of Health (NIH).

Researchers at the School of Medicine have developed a new imaging method to produce detailed 3D maps of uterine contractions in real time. The technology could help define the progression of healthy labor and identify when problems may be developing, such as in preterm labor or labor arrest.

Rajendra S. Apte, MD, PhD, in the John F. Hardesty, MD, Department of Ophthalmology & Visual Sciences at the School of Medicine, has received the 2023 Ernst H. Bárány Prize from the International Society for Eye Research.

A team of researchers led by Guy Genin, at the Center for Engineering MechanoBiology and the McKelvey School of Engineering, explores new approaches to surgical tendon-to-bone repair.

People who have had COVID-19 are at increased risk of developing gastrointestinal (GI) disorders within a year after infection, according to an analysis of federal health data by researchers at the School of Medicine and the Veterans Affairs St. Louis Health Care system.

Christopher J. Dy, MD, an associate professor of orthopedic surgery at the School of Medicine, is the recipient of the 2023 Kappa Delta Young Investigator Award for his research on brachial plexus injuries.

For older adults with clinical depression that has not responded to standard treatments, adding the drug aripiprazole to an antidepressant they’re already taking is more effective than switching from one antidepressant to another, according to a study led by the School of Medicine.

Timothy Miller, MD, PhD, the David Clayson Professor of Neurology at the School of Medicine, has been named a winner of the Rainwater Annual Prize for Outstanding Innovation in Neurodegenerative Disease Research.